Apple Watch Series 11 Introduces Hypertension Detection Feature

Apple recently unveiled its latest smartwatch, the Apple Watch Series 11, which includes a new hypertension detection feature. This capability aims to alert users to potential high blood pressure, a condition affecting approximately 1.3 billion people globally, many of whom remain undiagnosed. The feature will be available for order starting September 19, 2025, and is expected to roll out in 150 countries, including the United States and European Union.

US FDA clears Apple Watch hypertension feature

The hypertension detection feature utilizes the existing optical heart sensor on the Apple Watch to analyze changes in blood volume as the heart beats. The algorithm reviews heart signals over a 30-day period and alerts users if it detects consistent signs of hypertension. However, Apple emphasizes that these alerts do not constitute a medical diagnosis, and users are encouraged to follow up with a healthcare professional for confirmation using traditional cuff-based blood pressure monitors.

Apple explains Apple Watch high blood pressure warningsThe ConversationUS FDA clears Apple Watch hypertension feature

The U.S. Food and Drug Administration (FDA) has cleared Apple to market this hypertension detection feature, which is integrated into the Apple Watch Series 9 and later models, including the Ultra 2 and Ultra 3. Apple has stated that while the feature may not detect every case of high blood pressure, it could potentially notify over a million users of undiagnosed hypertension within its first year of release.

US FDA clears Apple Watch hypertension featureApple explains Apple Watch high blood pressure warningsI tested the Apple Watch Series 11 for a week – here’s my buying advice now

Despite the promise of improved hypertension detection, experts caution that cuffless devices, including the Apple Watch, are not currently recommended by clinical guidelines due to concerns about their accuracy. Critics point out that the lack of standardized testing protocols for cuffless devices makes it difficult to evaluate their performance reliably. Additionally, there are concerns that the influx of alerts could overwhelm healthcare systems and lead to unnecessary anxiety among users.

The Conversation

While Apple claims that its hypertension detection feature could alert a significant number of users, the effectiveness of such technology in clinical settings remains uncertain. Studies are ongoing to assess how well these devices perform in real-world scenarios. Furthermore, the absence of comprehensive data on the accuracy of cuffless devices raises questions about their reliability compared to traditional methods.

The Conversation

As the Apple Watch Series 11 and its hypertension detection feature become available, users are advised to monitor their blood pressure using validated cuff-based devices if they receive alerts. Apple recommends maintaining a blood pressure log and consulting with healthcare professionals to ensure proper evaluation and management of any potential health concerns.

Apple explains Apple Watch high blood pressure warningsThe ConversationUS FDA clears Apple Watch hypertension feature

• “Alerts for “possible hypertension” are just that: a sign for a potential health concern that needs to be evaluated and confirmed in a health-care setting.” — Expert Commentary

The Conversation

• “This feature is not intended to diagnose, treat, or support ongoing therapy for high blood pressure.” — Apple Statement

Apple explains Apple Watch high blood pressure warnings

The introduction of the hypertension detection feature in the Apple Watch Series 11 marks a significant step in the integration of health technology into everyday life, aiming to enhance awareness and proactive monitoring of a prevalent health issue.

Apple explains Apple Watch high blood pressure warnings